Santarus Reviews

3.7
14 Reviews
Rating Trends
Recommend to a friend
Approve of CEO
Santarus President, CEO, and Director Gerald T. Proehl
Gerald T. Proehl
10 Ratings

Santarus Interviews

Interview Experience

Interview Experience

100%
0%
0%

Getting an Interview

Getting an Interview

50%
50%

Interview Difficulty

2.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Specialty Sales Professional Interview

    Accepted Offer
    Positive Experience
    Average Interview
    Accepted Offer
    Positive Experience
    Average Interview

    Application

    I applied through an employee referral. The process took 2 weeksinterviewed at Santarus.

    Interview

    Phone interview with local inVentiv recruiter, phone interview with hiring District Sales Manager, face to face interview with Regional Sales Director, hiring District Sales Manager, and inVentiv ERM.

    Interview Questions

Santarus Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.santarus.com
Headquarters San Diego, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (CAD) per year

Santarus is a bit controlling, but in this case it's okay. Santarus' flagship drug Glumetza improves glycemic control for type 2 diabetes patients and is marketed through a partnership with Depomed. It markets a similar drug, Cycloset, also to improve glycemic control for type 2 diabetes, through a distribution and license agreement with S2 Therapeutics and Veroscience. Santarus' lead product used to be Zegerid, a modified version of omeprazole, the proton pump inhibitor found in AstraZeneca's best-selling Prilosec for heartburn. But when Zegerid's patent ran out and its... More

Work at Santarus? Share Your Experiences

Santarus

 
Click to Rate
or